Who owns AMGN
3,015 institutions reported holding AMGN for 2026Q1, together 78% of the company, more than the 2,997 a quarter earlier.
3,015
Institutions reporting a position · as of 2026Q1 · up from 2,997 the quarter before
- Shares held by institutions
- 424.3M
Shares held by institutions · 78% of the company · long US equity positions only, as reported on Form 13F
- Reported value
- $149.1B
Reported value · at 2026-03-31 prices, not today's
- Top 5 holders
- 33%
Top 5 holders · of the whole company, between five filers
Details›
- Reporting quarter2026-03-31
- 2026Q1
- Quarters on record
- 52
- New positions
- 204
- Positions exited
- 194
- Added to
- 985
- Reduced
- 1,060
- Top 10 holdersof the company
- 42%
| Quarter | Filers | Shares | Reported value |
|---|---|---|---|
| 2026Q1 | 3,015 | 424.3M | $149.1B |
| 2025Q4 | 2,997 | 433.8M | $141.9B |
| 2025Q3 | 2,759 | 420.2M | $118.6B |
| 2025Q2 | 2,789 | 429.0M | $119.7B |
| 2025Q1 | 2,874 | 425.1M | $132.4B |
| 2024Q4 | 2,803 | 415.4M | $108.2B |
| 2024Q3 | 2,786 | 409.9M | $131.6B |
| 2024Q2 | 2,746 | 408.1M | $127.4B |
| 2024Q1 | 2,669 | 408.4M | $115.8B |
| 2023Q4 | 2,669 | 406.9M | $117.2B |
| 2023Q3 | 2,457 | 402.1M | $108.0B |
| 2023Q2 | 2,345 | 402.3M | $89.7B |
| 2023Q1 | 2,393 | 403.6M | $97.6B |
| 2022Q4 | 2,457 | 409.8M | $107.0B |
| 2022Q3 | 2,284 | 408.3M | $92.7B |
| 2022Q2 | 2,318 | 411.6M | $100.9B |
| Holder | Shares | % of company | Value |
|---|---|---|---|
| VANGUARD GROUP INC | 55.4M | 10% | $19.5B |
| BlackRock Inc. | 47.1M | 8.7% | $16.6B |
| STATE STREET CORP | 30.5M | 5.6% | $10.7B |
| Capital World Investors | 29.3M | 5.4% | $10.3B |
| MORGAN STANLEY | 15.8M | 2.9% | $5.57B |
| GEODE CAPITAL MANAGEMENT LLC | 15.4M | 2.8% | $5.41B |
| Charles Schwab Trust Co | 12.8M | 2.3% | $4.49B |
| PRIMECAP MANAGEMENT CO/CA/ | 8.9M | 1.6% | $3.12B |
| JPMORGAN CHASE & CO | 7.3M | 1.3% | $2.54B |
| WELLS FARGO & COMPANY/MN | 7.2M | 1.3% | $2.52B |
SEC Form 13F data sets (DERA bulk files). 13F is quarterly, filed up to 45 days late, and covers long US equity positions only, no shorts, no derivatives, nothing held below the reporting threshold.
reading the register…
Drug Manufacturers - General
Ranks #5 of 16 by Smart Score